MAPK3 and lung cancer: The involvement of FAK-stimulated ERK1/2 signalling in fibronectin-induced A549 lung cancer cell migration and invasion was supported by our observation that these processes are inhibited in cells treated with PD98059, an inhibitor of the ERK1/2 upstream kinase, MEK.